Table 3.
Group | Age Group | Unvaccinated People | Single Dose | Complete Cycle |
---|---|---|---|---|
Population (3 July 2021) |
12–39 | 13,017,353 (74.7%) | 2,651,558 (15.2%) | 1,766,644 (10.1%) |
40–59 | 8,163,811 (44.3%) | 6,157,091 (33.4%) | 4,126,558 (22.4%) | |
60–79 | 3,118,561 (23.0%) | 4,825,699 (35.6%) | 5,628,519 (41.5%) | |
80+ | 446,128 (9.8%) | 245,504 (5.4%) | 3,862,475 (84.8%) | |
Diagnosis of SARS-CoV-2 (18 June 2021–18 July 2021) |
12–39 | 19,080 (81.0%) | 3313 (14.1%) | 1167 (5.0%) |
40–59 | 5457 (60.2%) | 2357 (26.0%) | 1256 (13.8%) | |
60–79 | 1446 (43.0%) | 1090 (32.4%) | 830 (24.7%) | |
80+ | 301 (33.2%) | 53 (5.8%) | 552(60.9%) |